Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Shinya Tsuboi"'
Autor:
Akihiro Uchiike, Haruka Kono, Katsuhiro Miura, Tatsuya Hayama, Daisuke Tsutsumi, Shinya Tsuboi, Susumu Ohtsuka, Shinji Hidaka
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 9, Iss 1, Pp 1-6 (2023)
Abstract Background Olanzapine treatment prevents chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC). However, its role in the secondary prevention of breakthrough CINV in real-world cancer care
Externí odkaz:
https://doaj.org/article/54aa38916aac42aca2221159a3bce4a2
Autor:
Shinya Tsuboi, Tatsuya Hayama, Katsuhiro Miura, Akihiro Uchiike, Daisuke Tsutsumi, Takashi Yamauchi, Yoshihiro Hatta, Susumu Ootsuka
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 9, Iss 1, Pp 1-5 (2023)
Abstract Background Pegfilgrastim is widely used for the prevention of febrile neutropenia (FN) in patients receiving myelosuppressive chemotherapy for various types of cancer. However, pegfilgrastim-induced bone pain (PIBP) is a relevant adverse eve
Externí odkaz:
https://doaj.org/article/971b7101717b4b708af2d32b96a7af91
Autor:
Shinya Tsuboi, Tatsuya Hayama, Katsuhiro Miura, Akihiro Uchiike, Daisuke Tsutsumi, Takashi Yamauchi, Yoshihiro Hatta, Susumu Ootsuka
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 9, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/ad4e889a21c0428fa3e9cc7b3d559649
Autor:
Daisuke Tsutsumi, Tatsuya Hayama, Katsuhiro Miura, Akihiro Uchiike, Shinya Tsuboi, Susumu Otsuka, Yoshihiro Hatta, Yukinaga Kishikawa
Publikováno v:
International Journal of Clinical Pharmacy. 44:366-373
Background Infusion-related reactions (IRRs) during rituximab administration are occasionally severe and remain problematic in oncology practice. Aim To establish a safer, risk-stratified rituximab protocol for patients with B-cell lymphoma. Method W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a542f91a29bbe2ee3dd99157ba9f6dd5
https://doi.org/10.1007/s11096-021-01348-6
https://doi.org/10.1007/s11096-021-01348-6
Autor:
Yoshihiro Hatta, Yukinaga Kishikawa, Tatsuya Hayama, Akihiro Uchiike, Susumu Otsuka, Katsuhiro Miura, Daisuke Tsutsumi, Shinya Tsuboi
Background Rituximab is widely used as a key component of immunochemotherapy to treat B-cell non-Hodgkin lymphoma (B-NHL). However, infusion-related reactions (IRRs) during drug administration are occasionally severe or even life-threatening and thus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::507f9aab4cd1e10f604761e397063f67
https://doi.org/10.21203/rs.3.rs-909741/v1
https://doi.org/10.21203/rs.3.rs-909741/v1
Autor:
Yoshihiro Hatta, Takashi Yamauchi, Yukinaga Kishikawa, Shinya Tsuboi, Daisuke Tsutsumi, Susumu Ootsuka, Katsuhiro Miura, Akihiro Uchiike, Isamu Odagiri, Tatsuya Hayama
Publikováno v:
Blood. 138:1934-1934
Introduction: Rituximab is widely used as the standard treatment for most types of B-cell non-Hodgkin lymphomas (B-NHL). However, infusion-related reactions (IRRs), such as fever, chills, nausea, rashes, rigors, or hypotension, are a significant burd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fc9a219d674ffe43994fd221e1b3215
https://doi.org/10.1182/blood-2021-145088
https://doi.org/10.1182/blood-2021-145088
Autor:
Shinsaku Washinosu, Yoshikazu Yoshida, Katsuhiro Miura, Kenichi Sakurai, Shinya Tsuboi, Masami Takei, Tatsuya Hayama, Akihiro Uchiike
Publikováno v:
International journal of clinical pharmacy. 40(5)
Background Pegfilgrastim is widely used for prophylaxis of febrile neutropenia (FN) in cancer patients receiving chemotherapies. However, the optimal timing of pegfilgrastim administration has not been established. Objective We investigated the effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8b62b9f87e3dbba6932735874b5319f
https://pubmed.ncbi.nlm.nih.gov/30953273
https://pubmed.ncbi.nlm.nih.gov/30953273
Publikováno v:
Fusion Engineering and Design. 10:303-308
Solubility measurements of hydrogen and deuterium gases in pure titanium and titanium—oxygen alloys with 10–30 at %O have been performed in the temperature range of 600–850°C at pressures below 100 Pa by a constant-volume method. All the solub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d70280452cc56930954cf18a03440327
https://doi.org/10.1016/0920-3796(89)90068-9
https://doi.org/10.1016/0920-3796(89)90068-9